Pregabalin safety profile
Pro Research Analysisby 
Searched over 200M research papers
Overview of Pregabalin Safety Profile
Pregabalin is widely used for neuropathic pain, fibromyalgia, generalized anxiety disorder, and other conditions. Its safety profile has been evaluated in numerous clinical trials and observational studies, consistently showing that it is generally well tolerated with mostly mild to moderate side effects Toth2012Arnold2012Toth2014+2 MORE.
Common Adverse Effects of Pregabalin
The most frequently reported side effects of pregabalin are dizziness, somnolence (sleepiness), peripheral edema (swelling), dry mouth, and weight gain Toth2012Arnold2012Shukla2021+4 MORE. These effects are usually mild to moderate in severity and often improve with continued use Arnold2012Owen2007Gerardi2016. In long-term studies, the incidence and severity of these adverse events remained stable, and most patients tolerated the medication well over time Arnold2012Gerardi2016.
Comparison with Other Medications
When compared to amitriptyline, another common treatment for neuropathic pain, pregabalin was associated with fewer and milder adverse drug reactions. Most side effects with pregabalin were mild, while those with amitriptyline were more often moderate in severity .
Serious and Rare Adverse Effects
Serious adverse effects with pregabalin are rare. There is very limited evidence of metabolic, idiosyncratic, or teratogenic (birth defect-causing) effects Toth2012Toth2014. No serious adverse drug reactions were observed in large clinical trials, and the overall safety profile was similar between immediate-release and controlled-release formulations Lee2020Huffman2017.
Withdrawal and Dependence
Pregabalin has a low potential for causing withdrawal symptoms. When discontinuing long-term therapy, it is recommended to taper the dose over at least one week to minimize any withdrawal effects, which are generally mild Owen2007Baldwin2015.
Special Populations and Long-Term Use
Pregabalin’s safety profile is consistent across different patient populations, including those with fibromyalgia, generalized anxiety disorder, and liver cirrhosis. In studies lasting up to one year, the adverse event profile did not change significantly, and the medication remained well tolerated Arnold2012Ahn2022Gerardi2016+1 MORE.
Clinical Implications
Pregabalin is considered a safe and effective option for managing neuropathic pain, fibromyalgia, and anxiety disorders. Its side effects are predictable, mostly mild, and manageable in clinical practice. The risk/benefit ratio favors its use, especially when compared to some alternative medications Toth2012Shukla2021Toth2014+2 MORE.
Conclusion
Overall, pregabalin has a favorable safety profile characterized by mild to moderate side effects such as dizziness, somnolence, and peripheral edema. Serious adverse events are rare, and the drug is well tolerated in both short-term and long-term use across various conditions. Pregabalin remains a reliable choice for clinicians managing chronic pain and anxiety disorders.
Sources and full results
Most relevant research papers on this topic